FutureMind Congress: Psychiatry, Psychosomatic Medicine & Mental Health Innovation 2026 is a premier global forum where science, clinical care, and innovation converge to reshape mental health. In London over two days, leaders from around the world in psychiatry, psychosomatic research, neuroscience, and digital health will come together to share new knowledge, debate paradigms, and launch scalable solutions. This congress is not just about academic exchange — it’s about turning ideas into impact. With keynotes, symposia, workshops, case sessions, and tech showcases, we aim to close the gap between research and real-world use. FutureMind is built to be actionable, inclusive, and future-oriented — a place where attendees don’t just listen but leave ready to transform care delivery Long-acting injectables and depot formulations: Exploring innovations in sustained-release medications that improve adherence and reduce relapse. Precision dosing and pharmacogenomics: How genetic insights and biomarkers personalize treatment and minimize adverse effects. Novel mechanisms in psychopharmacology: New targets such as glutamatergic pathways, immune modulators, and neuropeptides in development. Adjunctive and augmentation strategies: Combination approaches to enhance outcomes in treatment-resistant disorders. Managing safety, side effects, and metabolic risk: Best practices in monitoring and mitigating adverse drug effects. Tapering, withdrawal, and long-term maintenance care: Guidelines for discontinuation and ensuring sustainable recovery.

Description supplied by the event organiser.